Futura Medical (LON:FUM) announced its quarterly earnings results on Wednesday. The company reported GBX (0.44) (($0.01)) earnings per share for the quarter, Digital Look Earnings reports.

Futura Medical stock traded down GBX 0.50 ($0.01) during midday trading on Friday, reaching GBX 15.50 ($0.20). 153,237 shares of the company were exchanged, compared to its average volume of 960,258. The company has a market capitalization of $38.07 million and a price-to-earnings ratio of -3.52. The firm’s 50-day simple moving average is GBX 16.33 and its 200-day simple moving average is GBX 14.40. Futura Medical has a 1 year low of GBX 7.16 ($0.09) and a 1 year high of GBX 36 ($0.47).

Separately, Liberum Capital restated a “buy” rating on shares of Futura Medical in a research report on Tuesday, July 14th.

Futura Medical Company Profile

Futura Medical plc develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual healthcare and pain relief management. The company offers CSD500, a condom that incorporates an erectogenic gel to help men maintain a firmer erection during intercourse whilst wearing a condom.

See Also: What kind of dividend yield to CEF’s pay?

Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.